Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Research scientist uses her experiences as a physician to design studies that focus on and can improve care for people with early-onset type 2 diabetes.
Vaccine Study Center to lead effort searching medical records for serious reactions By Jan Greene New vaccines recently approved to protect against COVID-19 disease were developed at record speed. To support public confidence in the massive vaccination effort under way…
New study is first to quantify and compare the effects of long-term exposure to small particle pollution on risk for different types of cardiovascular disease.
Adolescents who had access to a brief intervention and referral to treatment for substance use or mood problems at a pediatric clinic were less likely to have a related diagnosis 3 years later, new Kaiser Permanente research finds.
Pregnant women who exercised more during the first trimester of pregnancy had a lower risk of developing gestational diabetes, a new analysis of Kaiser Permanente data finds.
People can look to the Northern European side of their genetic heritage for increased risk of nonmelanoma skin cancer, according to the first large analysis of genetic risk factors for cutaneous squamous cell carcinoma in diverse populations with European ancestry from Kaiser Permanente researchers.
New Kaiser Permanente study aims to help providers improve the health of patients most likely to sustain high medical costs, frequently use the emergency department, or need to be hospitalized.
The potential for statins — a widely prescribed class of cholesterol-lowering medication — to reduce the risk of Alzheimer’s disease and related dementias will be explored in a 4-year study led by Division of Research investigator Catherine Schaefer, PhD.
Four research fellows recently joined the Division of Research postdoc program, embarking on a unique pathway for career development.
To help pregnant women make informed decisions, Division of Research (DOR) investigator Lyndsay Avalos, PhD, MPH is leading a study to shed light on the nuances of depression treatment during pregnancy. Avalos recently received a $3 million grant from the National Institutes of Health to study the topic.